Follow
Fernanda Heloise Côrtes
Fernanda Heloise Côrtes
Verified email at ioc.fiocruz.br
Title
Cited by
Cited by
Year
Humoral and cellular immune memory to four COVID-19 vaccines
Z Zhang, J Mateus, CH Coelho, JM Dan, CR Moderbacher, RI Gálvez, ...
Cell 185 (14), 2434-2451. e17, 2022
3572022
HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles
FH Côrtes, CPB Passaes, G Bello, SLM Teixeira, C Vorsatz, D Babic, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 377-385, 2015
452015
Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection
HHS de Paula, ACG Ferreira, DG Caetano, E Delatorre, SLM Teixeira, ...
Retrovirology 15, 1-11, 2018
442018
Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers
SSD de Azevedo, DG Caetano, FH Côrtes, SLM Teixeira, ...
Retrovirology 14, 1-13, 2017
422017
Plasmatic Levels of IL-18, IP-10, and Activated CD8+ T Cells Are Potential Biomarkers to Identify HIV-1 Elite Controllers With a True Functional Cure Profile
FH Côrtes, HHS De Paula, G Bello, M Ribeiro-Alves, SSD De Azevedo, ...
Frontiers in immunology 9, 1576, 2018
302018
HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells
DG Caetano, HHS de Paula, G Bello, B Hoagland, LM Villela, ...
PLoS One 15 (2), e0228745, 2020
292020
Isolamento, identificação e avaliação da atividade antileucêmica de alcaloides indólicos monoterpênicos de Tabernaemontana salzmannii A. DC., Apocynaceae
ER Figueiredo, IJC Vieira, JJ de Souza, R Braz-Filho, L Mathias, ...
Revista Brasileira de Farmacognosia 20, 75-81, 2010
242010
Reduction of HIV-1 reservoir size and diversity after 1 year of cART among Brazilian individuals starting treatment during early stages of acute infection
TF Leite, E Delatorre, FH Côrtes, ACG Ferreira, SW Cardoso, B Grinsztejn, ...
Frontiers in Microbiology 10, 145, 2019
172019
Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control
DG Caetano, FH Côrtes, G Bello, SLM Teixeira, B Hoagland, B Grinsztejn, ...
Retrovirology 15, 1-13, 2018
112018
Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B-and F1-than in C-infected subjects
FH Côrtes, G Bello, C Vorsatz, JH Pilotto, ML Guimarães, B Grinsztejn, ...
Vaccine 31 (7), 1106-1112, 2013
102013
A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up
DG Caetano, FH Côrtes, G Bello, SSD de Azevedo, B Hoagland, ...
BMC infectious diseases 19, 1-9, 2019
92019
Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals
DG Caetano, M Ribeiro-Alves, ED Hottz, LM Vilela, SW Cardoso, ...
Scientific Reports 12 (1), 6569, 2022
82022
Inflammasome genetic variants are associated with protection to clinical severity of COVID-19 among patients from Rio de Janeiro, Brazil
NBR de Sá, M Neira-Goulart, M Ribeiro-Alves, H Perazzo, KM Geraldo, ...
BioMed Research International 2022, 2022
62022
HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection
SSD de Azevedo, E Delatorre, FH Côrtes, B Hoagland, B Grinsztejn, ...
Aids 33 (3), 399-410, 2019
62019
Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP1
SSD de Azevedo, M Ribeiro-Alves, FH Côrtes, E Delatorre, ...
Retrovirology 17, 1-14, 2020
52020
Inflammasome genes polymorphisms are associated with progression to mechanical ventilation and death in a cohort of hospitalized COVID-19 patients in a reference hospital in …
M Neira-Goulart, NBR de Sá, M Ribeiro-Alves, H Perazzo, KM Geraldo, ...
Gene 865, 147325, 2023
32023
Differential gene expression of cytokines, receptors, and miRNAs in individuals living with HIV-1 and vaccinated against yellow fever
KV Macieira, DG Caetano, SMB De Lima, CBW Giacoia-Gripp, FH Côrtes, ...
Molecular Immunology 164, 58-65, 2023
22023
Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4+ T Cell Loss in HIV-1 Elite Controllers
SSD De Azevedo, FH Côrtes, E Delatorre, M Ribeiro-Alves, B Hoagland, ...
Frontiers in Microbiology 10, 673, 2019
22019
Neutralizing antibodies in HIV-1-infected Brazilian individuals
DV Almeida, MG Morgado, FH Côrtes, ML Guimaraes, L Mendonça-Lima, ...
AIDS Research and Human Retroviruses 29 (3), 488-492, 2013
22013
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
E Motta, LAB Camacho, M Cunha, AMB de Filippis, SMB Lima, M Costa, ...
AIDS 37 (15), 2319-2329, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20